Hospitals Protest Genentech’s Deeming Cancer Drugs as Specialty Meds

by Admin | October 30, 2014 9:27 am

October 30, 2014—Hospital groups are protesting Genentech’s decision to make them buy three very expensive and much-used cancer drugs exclusively through specialty distributors, saying the change is raising their costs and potentially compromising patient care without enhancing patient safety or supply-chain security.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2014/10/hospitals-protest-genentechs-deeming-cancer-drugs-as-specialty-meds/

---